FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2005388018> ?p ?o ?g. }

• W2005388018 endingPage "282" @default.
• W2005388018 startingPage "275" @default.
• W2005388018 abstract "Objective: To determine the effectiveness and costs of prophylaxis for disseminatedMycobacterium avium complex (MAC) infection in patients with AIDS. Design: A decision analysis model was constructed to compare rifabutin (300 mg/day), azithromycin (1200 mg/week), and clarithromycin (500 mg twice per day) with no prophylaxis. Sensitivity analysis was done on all model parameters, including initial CD4 count for beginning prophylaxis. Setting: The setting was hypothetical for the cost-effectiveness model. Clinical data were taken from published prospective randomized controlled trials. Main Outcome Measures: Outcomes were measured in terms of projected life expectancy, quality-adjusted life expectancy, direct medical costs, and cost-effectiveness in U.S. dollars per quality-adjusted life-year saved ($/QALY). Results: For patients with AIDS and those having CD4 counts <75 cells/mm3, azithromycin, clarithromycin, and rifabutin prophylaxis increased lifetime per person MAC-related costs by $994, $2,117, and $2,185 U.S., respectively. Quality-adjusted life expectancy increased from 1.6068 QALYs to between 1.6186 and 1.6255 QALYs. The cost-effectiveness ratios were $58,200, $116,000, and $179,100/QALY saved for azithromycin, clarithromycin, and rifabutin prophylaxis, respectively, each compared with no prophylaxis. Results were most dependent on the annual cost of prophylaxis, the initial CD4 count when starting prophylaxis, and any survival benefit with prophylaxis. For each type of prophylaxis, strategies beginning with CD4 counts <25 or 50 cells/mm3 were substantially more cost-effective than those beginning in patients with higher CD4 counts. Conclusions: MAC prophylaxis is likely to cost society an additional $99 to $219 million U.S. per 100,000 patients treated. In the context of Centers for Disease Control and Prevention (CDC) recommendations to use prophylaxis in patients with CD4 counts <75 cells/mm3, azithromycin represents the best value and is most cost-effective when used in patients with CD4 counts <25 cells/mm3." @default.
• W2005388018 created "2016-06-24" @default.
• W2005388018 creator A5023883867 @default.
• W2005388018 creator A5037765362 @default.
• W2005388018 creator A5074313423 @default.
• W2005388018 date "1997-08-01" @default.
• W2005388018 modified "2023-09-25" @default.
• W2005388018 title "Prophylaxis for Disseminated Mycobacterium avium Complex(MAC) Infection in Patients With AIDS" @default.
• W2005388018 cites W1975236619 @default.
• W2005388018 cites W1976337108 @default.
• W2005388018 cites W1977080085 @default.
• W2005388018 cites W1981949479 @default.
• W2005388018 cites W1996181066 @default.
• W2005388018 cites W2017983089 @default.
• W2005388018 cites W2024161208 @default.
• W2005388018 cites W2036734901 @default.
• W2005388018 cites W2041096865 @default.
• W2005388018 cites W2047232268 @default.
• W2005388018 cites W2068505375 @default.
• W2005388018 cites W2068977501 @default.
• W2005388018 cites W2069526707 @default.
• W2005388018 cites W2072767714 @default.
• W2005388018 cites W2080397181 @default.
• W2005388018 cites W2083224152 @default.
• W2005388018 cites W2092154130 @default.
• W2005388018 cites W2121879722 @default.
• W2005388018 cites W2131195032 @default.
• W2005388018 cites W2147466355 @default.
• W2005388018 cites W2168698799 @default.
• W2005388018 cites W2314152647 @default.
• W2005388018 cites W2314818521 @default.
• W2005388018 cites W2317892976 @default.
• W2005388018 cites W2318257110 @default.
• W2005388018 cites W2330928310 @default.
• W2005388018 cites W2336284588 @default.
• W2005388018 cites W2337305755 @default.
• W2005388018 cites W2338479447 @default.
• W2005388018 cites W2339838480 @default.
• W2005388018 cites W2341862408 @default.
• W2005388018 cites W2407217298 @default.
• W2005388018 cites W2618242172 @default.
• W2005388018 cites W4242386994 @default.
• W2005388018 cites W4242389719 @default.
• W2005388018 cites W4250903275 @default.
• W2005388018 doi "https://doi.org/10.1097/00042560-199708010-00005" @default.
• W2005388018 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9292586" @default.
• W2005388018 hasPublicationYear "1997" @default.
• W2005388018 type Work @default.
• W2005388018 sameAs 2005388018 @default.
• W2005388018 citedByCount "13" @default.
• W2005388018 crossrefType "journal-article" @default.
• W2005388018 hasAuthorship W2005388018A5023883867 @default.
• W2005388018 hasAuthorship W2005388018A5037765362 @default.
• W2005388018 hasAuthorship W2005388018A5074313423 @default.
• W2005388018 hasBestOaLocation W20053880181 @default.
• W2005388018 hasConcept C112930515 @default.
• W2005388018 hasConcept C126322002 @default.
• W2005388018 hasConcept C133925201 @default.
• W2005388018 hasConcept C142724271 @default.
• W2005388018 hasConcept C187212893 @default.
• W2005388018 hasConcept C2775961462 @default.
• W2005388018 hasConcept C2776409635 @default.
• W2005388018 hasConcept C2776688490 @default.
• W2005388018 hasConcept C2776962512 @default.
• W2005388018 hasConcept C2778602436 @default.
• W2005388018 hasConcept C2778907293 @default.
• W2005388018 hasConcept C2780374374 @default.
• W2005388018 hasConcept C2780867798 @default.
• W2005388018 hasConcept C2781069245 @default.
• W2005388018 hasConcept C2908647359 @default.
• W2005388018 hasConcept C3019080777 @default.
• W2005388018 hasConcept C501593827 @default.
• W2005388018 hasConcept C515549039 @default.
• W2005388018 hasConcept C64332521 @default.
• W2005388018 hasConcept C71924100 @default.
• W2005388018 hasConcept C86803240 @default.
• W2005388018 hasConcept C89423630 @default.
• W2005388018 hasConcept C99454951 @default.
• W2005388018 hasConceptScore W2005388018C112930515 @default.
• W2005388018 hasConceptScore W2005388018C126322002 @default.
• W2005388018 hasConceptScore W2005388018C133925201 @default.
• W2005388018 hasConceptScore W2005388018C142724271 @default.
• W2005388018 hasConceptScore W2005388018C187212893 @default.
• W2005388018 hasConceptScore W2005388018C2775961462 @default.
• W2005388018 hasConceptScore W2005388018C2776409635 @default.
• W2005388018 hasConceptScore W2005388018C2776688490 @default.
• W2005388018 hasConceptScore W2005388018C2776962512 @default.
• W2005388018 hasConceptScore W2005388018C2778602436 @default.
• W2005388018 hasConceptScore W2005388018C2778907293 @default.
• W2005388018 hasConceptScore W2005388018C2780374374 @default.
• W2005388018 hasConceptScore W2005388018C2780867798 @default.
• W2005388018 hasConceptScore W2005388018C2781069245 @default.
• W2005388018 hasConceptScore W2005388018C2908647359 @default.
• W2005388018 hasConceptScore W2005388018C3019080777 @default.
• W2005388018 hasConceptScore W2005388018C501593827 @default.
• W2005388018 hasConceptScore W2005388018C515549039 @default.
• W2005388018 hasConceptScore W2005388018C64332521 @default.
• W2005388018 hasConceptScore W2005388018C71924100 @default.

• next